Hangzhou LifeReal Biotechnology
PrivateLast Round
Series B
May 1, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hangzhou LifeReal Biotechnology is a medical supplies company that develops and produces life science and clinical diagnostic products.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou LifeReal Biotechnology Comparables
Compare Hangzhou LifeReal Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jiangsu Mole Bioscience Co., Ltd. | 86% | |
| Hangzhou Bigfish Bio-tech Co., Ltd. | 86% | |
| Coyote Bioscience Co., Ltd. | 83% |
Hangzhou LifeReal Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2022 | ||||
| Series A Extension | Jul 16, 2020 | ||||
| Series A | May 31, 2019 | ||||
| Angel | Apr 1, 2017 |
Hangzhou LifeReal Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zheshang Venture Capital | Series B, Series A Extension |
| YuanBio Venture Capital | Series B, Angel |
| GF Venture Capital | Series B |
| Huagai Capital | Series B, Series A |
| China Growth Capital | Series B, Series A Extension |
| Ennovation Ventures | Series B, Angel |
| 广发乾和投资有限公司 | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 95% MoM.
- May 15, 2026
Monthly visitors grew 191% MoM, reaching 704.
Hangzhou LifeReal Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou LifeReal Biotechnology's valuation, stock price, and market status.
Is Hangzhou LifeReal Biotechnology a public or private company?
Hangzhou LifeReal Biotechnology is a private company.
What is the current stock price of Hangzhou LifeReal Biotechnology?
Hangzhou LifeReal Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Hangzhou LifeReal Biotechnology worth (valuation)?
Valuation information for Hangzhou LifeReal Biotechnology is not publicly available.
Can I buy Hangzhou LifeReal Biotechnology stock?
Hangzhou LifeReal Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou LifeReal Biotechnology's last funding round?
Funding round information for Hangzhou LifeReal Biotechnology is not publicly available.
Who are the main investors in Hangzhou LifeReal Biotechnology?
Investor information for Hangzhou LifeReal Biotechnology is not publicly disclosed.
Will Hangzhou LifeReal Biotechnology IPO soon?
No public IPO plans have been announced for Hangzhou LifeReal Biotechnology.
How can I track Hangzhou LifeReal Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou LifeReal Biotechnology's secondary market activity and sign up for updates.